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Summary
Measurement of serum fructosamine and haemoglobin A,
levels and glucose tolerance tests were performed in 75
women in the immediate postpartum period. None had pre-
disposing factors to gestational diabetes. They were divided
into three groups: group I consisted of 15 women who
delivered an unexplained stillbirth; group 11 of 30 women who
gave birth to babies weighing between 2500 g and 3900 g at
term; and group III of 30 women who delivered babies
weighing;;' 4000 g. There was a significant difference in the
mean level of serum fructosamine between the unexplained
stillbirth and control groups (P < 0,001). Although the HbA,
values varied in the three groups, there was a significant
difference between the unexplained stillbirth group and the
macrosomic infant group (P < 0,05). All patients had normal
glucose tolerance tests.
S Atr Med J 1991; 79: 558-559.
Delivery of a macrosomic baby or unexplained stillbirth indi-
cates that the mother may have had abnormal glucose tolerance
during pregnancy. Glucose tolerance, however, rapidly returns
to normal after delivery in tHe gestational diabetic, reducing
the likelihood of detecring diabetes by standard methods, such
as an oral glucose tolerance test, in the pueperium. l
Serum fructosamine levels, a measure of keto-amine activity
(glycosylated proteins, mainly albumin), have been found to
be a good screening test for diabetes.2 Unlike blood glucose
levels, which change rapidly from minute to minute, and
glycosylated haemoglobin (HbA I ) values, which give an indi-
cation of mean blood glucose level over the preceding 6 - 8
weeks, serum fructosamine levels reflect glycaemia over the
preceding I - 3 weeks. 3 Estimation of serum fructosamine
levels performed immediately after delivery should, theoreti-
cally, be able to detect any carbohydrate intolerance present in
the last 2 weeks of gestation, whereas the diagnosis of gesta-
tional diabetes might be missed by HbA I measurement because
of its longer half-life.
. A study was undertaken to establish serum fructosamine
values immediately after delivery in women with no medical
complications who had delivered: (z) unexplained stillbirths;
(iz) average-sized babies; and (iiz) macrosomic babies (> 4000 g).
Patients and methods
The study was perfonned at King Edward VIII Hospital,
Durban, over a period of 1 year. Infonned consent was
obtained from 75 black women who had no predisposing
factors to gestational diabetes, viz. glycosuria, a family or past
history of diabetes, and a history of unexplained stillbirths or
neonatal deaths.
Excluded from the study were patients with a haemoglobin
level of < 10 gldl; albumin concentration of < 35 gIl; weight
of > 90 kg; positive serological test for syphilis; rhesus negative
blood; or a history of hypertension or renal disease. 'The
patients studied were divided into three groups. Group I
consisted of 15 patients who delivered an unexplained
macerated stillbirth, group II of 30 patients of similar age and
parity who had given birth to babies weighing between 2500 g
and 3900 g at term, and group III of 30 patients who
delivered babies weighing ~ 4 000 g.
Blood samples were taken after an overnight fast for the
measurement of serum fructosamine, glycosylated haemoglobin,
and rapid plasma reagin levels, haemoglobin value, blood
grouping (ABO and Rh), and liver function tests within 48
hours of delivery.
In addition, a 75 g oral glucose tole,ance test (OGTI) was
performed. Blood samples for glucose estimatiOI~ were taken in
tubes containing a fluoride oxalate mixture. Plasma glucose
levels were measured by the glucose oxidase method using a
Centrifichem System 500 analyser. The diagnosis Qf abnonnal
glucose tolerance was made according to World Health Orgahi-
sation criteria.4
Serum fructosamine was measured by a colorimetric method
using a commercial kit from Roche (Switzerland). The method
of Johnson er a/.,s was adapted for the Centrifichem analyser.
Glycated protein calibrated with deoxymorpholinofructose was
used as the standard. Both the intra- and inter-assay coefficients
of variation were < 3%.
HbA I was quantitated by cation-exchange chromatography
at 22°C. Controls were incorporated in each assay. Both the
intra- and inter-assay coefficients of variation were < 10%.
Statistics. Student's unpaired r-test' and Pearson's correla-
tion coefficient (r) were used to quantitate the correlation
between relevant variables.
Results
The clinical data are shown in Table I.
Serum fructosamine values are shown in Table II. There
was a significant difference in the mean level of fructosamine
between the unexplained stillbirth and control groups only
(2,27 v. 1,96 mmol; P < 0,001).
TABLE I. MEAN (RANGE) CLINICAL DATA
Group I Group 11 Group III
(N = 30) (N = 15) (N = 30)
27 25 26
2 1,5 2,5
1 490 3 020 4 200
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'p < 0,001
• p < 0,0005
two substances are very different and hence the two parameters
may not strictly conform. This poor correlation between glyco-
sylated haemoglobin and fructosamine level confirms the
fmdings of Ross er a/.s
According to WHO criteria4 glucose tolerance was normal
in all 75 patients. Serum fructosarnine values are an index of
the mean glucose levels 1 - 3 weeks before delivery. The
OGTT may have been normal in the 3 patients in group I who
had elevated serum fructosamine levels because of poor
placental function. This, however, does not rule out the possi-
bility that the 3 patients may have had glucose intolerance in
the predelivery period.
HbA I gives a mean glucose reading for the preceding 8 - 12
weeks. The patients with elevated HbA lc in group III may
have had normal OGTTs because there are other causes for
macrosomia and these may overlap with HbA I values in
normal patients and known diabetics. Further studies deter-
mining the levels of serum fruetosamine and HbA I in known
pregnant diabetics in the post-delivery period are therefore
necessary.
It is well known that the fasting plasma glucose concentration
is reduced during pregnancy.9 The difference in the fasting
blood glucose in group I and group 11 may have been as a
result of some degree of intolerance in the former.
Although serum fruetosarnine value gives a good index of
mean control in the preceding 1 - 3 weeks,3 it cannot be used
as a screening test for diabetes in the immediate postpartum
period, since it does not correlate with birth weight. This is
not surprising, since there are other causes for macrosomia.
Elevated levels of serum fruetosarnine in the post-delivery
period in the presence of a normal OGTT in patients who
deliver unexplained stillbirths does not rule out the possibility
that there may have been glucose intolerance.
Since the serum fruetosarnine assay is in its early stages, we
recommend that initially it should be used interchangeably
with HbA I estimations.
In conclusion, serum fruetosamine levels cannot be used as
a screening test for diabetes in the immediate postpartum
period, since it does not correlate with birth weight. However,
it is a good index of the mean control in the preceding I - 3





TABLE IV. HbA, LEVELS(%)
. Group I Group 11
6,4* 7,0
5,2 - 8,3 5,6 - 9,1
TABLE Ill. PLASMA GLUCOSE. LEVELS (mmol/l)
Group I Group 11 Group III
4,5* 3,9* 4,3
3,7 - 5,1 3,1 - 5,0 3,1 - 5,2
6,3 5,5 5,9
4,7·9,9 4,0 - 7,7 4,2 - 10,4
TABLE 11. SERUM FRUCTOSAMINE VALUES (mmol/l)
Group I Group 11 Group III
2,27* 1,96* 2,07









Although the HbA I values were inconsistent in the three
groups (Table IV), there was a significant difference between
group I and group III (P < 0,05). There was no significant
difference between group I and group 11 or between group III
and group 11.
Plasma glucose results are set out in Table Ill. All 75
patients in the study had normal glucos.e tolerance tests. There
wliS a significant difference in the fasting blood sugar values
be~een group I and group 11 (4,5 v. 3;9 mmol/l; P < 0,0005).
nere was no significant difference between group III and
gr<>UP 11.. Although the 2-hour blood sugar a~e~ no statis-
tical significance, the mean blood sugar was higher m groups I
anI! III compared with group 11.
.p < 0.05 REFERENCES
Discussion
There is conflicting evidence regarding the correlation between
HbA I values and birth weight. Widness er al.6 found a good
cortelation, whereas Coen er a/.7 reported contradictory
fmdings. The present study showed no significant difference
between the mean HbA I and serum 'fruetosamine levels in
grOllPS III and 11.
The serum fruetosarnine level was elevated in 3 patients in
grOllP I and in 2 patients in group Ill; whereas HbA I was
eleVated in 3 different patients in group Ill. A possible
expl.anation for this discrepancy is that the half-lives of these
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